Kimberly Rutledge
Family · Oskaloosa, IANPI 1942660204
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.7% of the total across 300 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,667 and has fallen 86.3% since, to $228 in 2025. Among family clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $15.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$949
- Otsuka America Pharmaceutical, Inc.$546
- Teva Pharmaceuticals USA, Inc.$474
- Johnson & Johnson$469
- Vanda Pharmaceuticals Inc.$435
- Lundbeck LLC$413
- plus $1K from 9 others
What the payments were for
- Food & beverage$4,67399%
- Education$601%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 65 | $949 |
| Otsuka America Pharmaceutical, Inc. | 37 | $546 |
| Teva Pharmaceuticals USA, Inc. | 29 | $474 |
| Johnson & Johnson | 30 | $469 |
| Vanda Pharmaceuticals Inc. | 22 | $435 |
| Lundbeck LLC | 30 | $413 |
| Alkermes, Inc. | 22 | $388 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $270 |
| Ironshore Pharmaceuticals Inc. | 16 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $187 |
| Neurocrine Biosciences, Inc. | 8 | $135 |
| Corium, LLC | 8 | $92 |
| Supernus Pharmaceuticals, Inc. | 5 | $77 |
| Sunovion Pharmaceuticals Inc. | 2 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
How this compares
$4,733 in reported general payments places this provider in the 95th percentile of 1,268 family providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 49 | $68,674 |
| RexultiBrexpiprazole | 22 | $37,485 |
| Invega SustennaPaliperidone Palmitate | 11 | $36,999 |
| TrintellixVortioxetine Hydrobromide | 54 | $28,742 |
| Clozapine | 34 | $2,898 |
| Aripiprazole | 105 | $2,610 |
| Prazosin Hcl | 160 | $2,454 |
| Buspirone Hcl | 181 | $2,447 |
| Duloxetine Hcl | 118 | $2,278 |
| Quetiapine Fumarate | 140 | $2,034 |
| Olanzapine | 42 | $1,448 |
| Divalproex Sodium | 37 | $1,288 |
| Bupropion XlBupropion Hcl | 59 | $1,287 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 85 | $1,268 |
| Trazodone Hcl | 120 | $1,251 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $949 | $68,67449 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $546 | $37,48522 claims |
| Johnson & JohnsonInvega Sustenna | $469 | $36,99911 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $187 | $28,74254 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,268 family providers in Iowa.
Other family in Oskaloosa
- Stefanie GaticaAnkeny$354K
- Aubrey MolgaardAmes$238K
- Joan KittenFort Dodge$85K
- Megan FergusonPella$82K
- Rodney ClarkDes Moines$63K
- Jennifer CondonFort Dodge$31K
- Karen HunkeAmes$20K
- Tonia AckermanWest Des Moines$17K
- Chi-Ying SageWaterloo$14K
- Amanda GaldiNorth Liberty$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.